These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8501569

  • 1. Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children.
    Rascher W, Kremens B, Wagner S, Feth F, Hunneman DH, Lang RE.
    J Pediatr; 1993 Jun; 122(6):914-6. PubMed ID: 8501569
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide Y as a marker in pediatric neuroblastoma.
    Kogner P, Björk O, Theodorsson E.
    Pediatr Pathol; 1990 Jun; 10(1-2):207-16. PubMed ID: 2315229
    [Abstract] [Full Text] [Related]

  • 3. Plasma neuropeptide Y of children with neuroblastoma in relation to stage, age and prognosis, and tissue neuropeptide Y.
    Dötsch J, Christiansen H, Hänze J, Lampert F, Rascher W.
    Regul Pept; 1998 Sep 25; 75-76():185-90. PubMed ID: 9802408
    [Abstract] [Full Text] [Related]

  • 4. Tumour markers are poor predictors for relapse or progression in neuroblastoma.
    Simon T, Hero B, Hunneman DH, Berthold F.
    Eur J Cancer; 2003 Sep 25; 39(13):1899-903. PubMed ID: 12932669
    [Abstract] [Full Text] [Related]

  • 5. The value of determination of homovanillic and vanillylmandelic acids in plasma for the diagnosis and follow-up of neuroblastoma in children.
    Gahr M, Hunneman DH.
    Eur J Pediatr; 1987 Sep 25; 146(5):489-93. PubMed ID: 3678274
    [Abstract] [Full Text] [Related]

  • 6. Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma and neuroblastoma.
    Mouri T, Sone M, Takahashi K, Itoi K, Totsune K, Hayashi Y, Hasegawa S, Ohneda M, Murakami O, Miura Y.
    Clin Sci (Lond); 1992 Aug 25; 83(2):205-11. PubMed ID: 1327637
    [Abstract] [Full Text] [Related]

  • 7. Significance of plasma neuropeptide Y (NPY) in diagnosis and prognosis of neuroblastoma.
    Hayashi Y, Ohi R, Sone M, Takahashi K, Mouri T, Watanabe T, Yaoita S, Nakamura M.
    Prog Clin Biol Res; 1991 Aug 25; 366():359-65. PubMed ID: 2068151
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.
    Berthold F, Hunneman DH, Harms D, Käser H, Zieschang J.
    Eur J Cancer; 1992 Aug 25; 28A(12):1950-4. PubMed ID: 1419287
    [Abstract] [Full Text] [Related]

  • 10. Plasma neuropeptide Y (NPY): a novel marker of neuroblastoma.
    Kogner P, Theodorsson E, Björk O.
    Prog Clin Biol Res; 1991 Aug 25; 366():367-73. PubMed ID: 2068152
    [No Abstract] [Full Text] [Related]

  • 11. Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts.
    Kogner P, Björk O, Theodorsson E.
    Med Pediatr Oncol; 1993 Aug 25; 21(5):317-22. PubMed ID: 8492745
    [Abstract] [Full Text] [Related]

  • 12. Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.
    Sadilkova K, Dugaw K, Benjamin D, Jack RM.
    Clin Chim Acta; 2013 Sep 23; 424():253-7. PubMed ID: 23830883
    [Abstract] [Full Text] [Related]

  • 13. Determination of serum catecholamine metabolites in neuroblastoma by high performance liquid chromatography with electrochemical detection.
    Tang QM, Xu XR, Shi YQ, Jin BX.
    Biomed Chromatogr; 1986 Feb 23; 1(1):7-11. PubMed ID: 3506818
    [Abstract] [Full Text] [Related]

  • 14. [Value of the determination of serum catecholamine metabolites in the early diagnosis of neuroblastoma].
    Shi YQ.
    Zhonghua Yi Xue Za Zhi; 1987 Mar 23; 67(3):150-1. PubMed ID: 3111662
    [No Abstract] [Full Text] [Related]

  • 15. Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas.
    Grouzmann E, Gicquel C, Plouin PF, Schlumberger M, Comoy E, Bohuon C.
    Cancer; 1990 Oct 15; 66(8):1833-5. PubMed ID: 2208039
    [Abstract] [Full Text] [Related]

  • 16. Elevated plasma concentrations of neuropeptide Y in children and adults with chronic and terminal renal failure.
    Bald M, Gerigk M, Rascher W.
    Am J Kidney Dis; 1997 Jul 15; 30(1):23-7. PubMed ID: 9214397
    [Abstract] [Full Text] [Related]

  • 17. Plasma neuropeptide Y concentrations in patients with neuroendocrine tumors.
    Grouzmann E, Comoy E, Bohuon C.
    J Clin Endocrinol Metab; 1989 Apr 15; 68(4):808-13. PubMed ID: 2466046
    [Abstract] [Full Text] [Related]

  • 18. Plasma levels of chromogranin A are directly proportional to tumour burden in neuroblastoma.
    Wassberg E, Stridsberg M, Christofferson R.
    J Endocrinol; 1996 Nov 15; 151(2):225-30. PubMed ID: 8958782
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
    Hero B, Hunneman DH, Gahr M, Berthold F.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):220-3. PubMed ID: 11464889
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.